THE EFFECTS OF CHLOROQUINE, PARACETAMOL AND PROMETHAZINE ON THE PHARMACOKINETICS OF CHLORPROPAMIDE IN HUMAN VOLUNTEERS

Simple item page
dc.contributor.authorDANLAMI, UZAMA
dc.date.accessioned2014-02-18T12:56:39Z
dc.date.available2014-02-18T12:56:39Z
dc.date.issued2008-03
dc.descriptionA DISSERTATION SUBMITTED TO THE POSTGRADUATE SCHOOL IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE AWARD OF THE DEGREE OF DOCTOR OF PHILOSOPHY IN PHARMACEUTICAL CHEMISTRY DEPARTMENT OF PHARMACEUTICAL AND MEDICINAL CHEMISTRY FACULTY OF PHARMACEUTICAL SCIENCES AHMADU BELLO UNIVERSITY ZARIA NIGERIA MARCH 2008en_US
dc.description.abstractThe effect of chloroquine, paracetamol and Promethazine on the pharmacokinetic profile of chlorpropamide was investigated in human subjects. The batches of chlorpropamide, chloroquine, paracetamol and Promethazine used were subjected to quality control studies using official methods. The drugs complied with the B.P (1993) requirements stated in their monographs. A high performance liquid chromatography (HPLC) method was developed for the analysis of plasma chlorpropamide concentration. Pharmacokinetic parameters of chlorpropamide were derived with Winnonlin standard noncompartment software programme. About 16%, 14% and 15% decrease in the mean maximum concentration (Cmax) of chlorpropamide was observed following oral administration of chlorpropamide with chloroquine, paracetamol and Promethazine respectively. About 44%, 11% and 30% decrease in the area under curve (AUC) of chlorpropamide was observed following concurrent administration of chlorpropamide with chloroquine, paracetamol and Promethazine respectively. The plasma clearance of chlorpropamide increased by 86% following chlorpropamide interaction with chloroquine. The absorption half-life (t½a) of chlorpropamide increased by 4%, 85% and 69% when concomitantly administered with chloroquine, paracetamol and Promethazine respectively. The elimination constant (Kel) of chlorpropamide was found to have increased by 100% and decreased by 31% following concomitant administration of chlorpropamide with chloroquine and paracetamol respectively. The elimination half-life (t½el) of chlorpropamide was found to have decreased by 47% and increased by 13% and 29% following concomitant administration to chlorpropamide with chloroquine, paracetamol and Promethazine respectively. The study implied impaired absorption and elimination of chlorpropamide by chloroquine, paracetamol and Promethazine.en_US
dc.identifier.urihttp://hdl.handle.net/123456789/1993
dc.language.isoenen_US
dc.subjectEFFECTS,en_US
dc.subjectCHLOROQUINE,en_US
dc.subjectPARACETAMOL,en_US
dc.subjectPROMETHAZINE,en_US
dc.subjectPHARMACOKINETICS,en_US
dc.subjectCHLORPROPAMIDE,en_US
dc.subjectHUMAN,en_US
dc.subjectVOLUNTEERSen_US
dc.titleTHE EFFECTS OF CHLOROQUINE, PARACETAMOL AND PROMETHAZINE ON THE PHARMACOKINETICS OF CHLORPROPAMIDE IN HUMAN VOLUNTEERSen_US
dc.typeThesisen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
THE EFFECTS OF CHLOROQUINE, PARACETAMOL AND PROMETHAZINE ON THE PHARMACOKINETICS OF CHLORPROPAMIDE IN HUMAN VOLUNTEERS.pdf
Size:
694.25 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.58 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
PHARMACEUTICAL SCIENCES